Risk factors for infection after liver transplantation

Best Practice and Research: Clinical Gastroenterology

Volumn 26, Issue 1, 2012, Pages 61-72

  Van Hoek, Bart ^a   De Rooij, Bert Jan ^a   Verspaget, Hein W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bacteria; ComplementMannan binding lectin; Donor; Ficolin; Fungus; Infection; Innate immunity; Liver transplantation; MBL associated serine proteases; Recipient; Risk factors; Toll like receptors; Virus

Indexed keywords

ACICLOVIR; ADEFOVIR DIPIVOXIL; BASILIXIMAB; CYCLOSPORIN A; ENTECAVIR; LAMIVUDINE; LECTIN; PEGINTERFERON; PREDNISOLONE; PROTEINASE INHIBITOR; RIBAVIRIN; TACROLIMUS; TENOFOVIR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; VALGANCICLOVIR;

ACUTE LIVER FAILURE; AFRICAN AMERICAN; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; ASPERGILLOSIS; BACTERIAL CELL WALL; BILE DUCT INJURY; BILE DUCT OBSTRUCTION; BILIARY TRACT DRAINAGE; BLOOD TRANSFUSION; CAUCASIAN; CHOLANGITIS; CHOLEDOCHOJEJUNOSTOMY; CHRONIC ACTIVE HEPATITIS; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; COMPLEMENT ACTIVATION; CYSTIC FIBROSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIALYSIS; ENVIRONMENTAL FACTOR; FUNGAL COLONIZATION; GENETIC POLYMORPHISM; GRAFT RECIPIENT; HEPATIC ARTERY; HEPATITIS B; HEPATITIS C; HERPES VIRUS; HERPES VIRUS INFECTION; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INTENSIVE CARE; INVASIVE CANDIDIASIS; KIDNEY FAILURE; LIVER GRAFT REJECTION; LIVER NECROSIS; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; POSTOPERATIVE INFECTION; REOPERATION; REPERFUSION INJURY; SINGLE NUCLEOTIDE POLYMORPHISM; STEATOSIS; SURGICAL INFECTION; SURGICAL MORTALITY; TRAVEL; VIRUS REACTIVATION; WOUND DEHISCENCE;

BACTERIAL INFECTIONS; COMPLEMENT ACTIVATION; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; OPPORTUNISTIC INFECTIONS; POLYMORPHISM, GENETIC; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TISSUE DONORS; VIRUS DISEASES;

EID: 84859344817     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2012.01.004     Document Type: Article

References (106)

1. F.H. Saner, S.W. Olde Damink, G. Pavlakovic, M.A. van den Broek, P.M. Rath, and G.C. Sotiropoulos Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients Transplantation 85 2008 1564 1568
2. A. Vera, F. Contreras, and F. Guevara Incidence and risk factors for infections after liver transplant: single-center experience at the University Hospital Fundacion Santa Fe de Bogota, Colombia Transpl Infect Dis 13 2011 608 615
3. F.A. Romero, and R.R. Razonable Infections in liver transplant recipients World J Hepatol 3 2011 83 92
4. J.A. Fishman Infection in solid-organ transplant recipients N Engl J Med 357 2007 2601 2614 (Pubitemid 350294226)
5. J.A. Fishman, and N.C. Issa Infection in organ transplantation: risk factors and evolving patterns of infection Infect Dis Clin North Am 24 2010 273 283
6. S. Janny, F. Bert, F. Dondero, F. Durand, P. Guerrini, and P. Merckx Microbiological findings of culture-positive preservation fluid in liver transplantation Transpl Infect Dis 13 2011 9 14
7. M. Matignon, F. Botterel, V. Audard, B. Dunogue, K. Dahan, and P. Lang Outcome of renal transplantation in eight patients with Candida sp. contamination of preservation fluid Am J Transplant 8 2008 697 700 (Pubitemid 351287544)
8. A.B. Benson, J.R. Burton Jr., G.L. Austin, S.W. Biggins, M.A. Zimmerman, and I. Kam Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation Liver Transpl 17 2011 149 158
9. J. Dubbeld, H. Hoekstra, W. Farid, J. Ringers, R.J. Porte, and H.J. Metselaar Similar liver transplantation survival with selected cardiac death donors and brain death donors Br J Surg 97 2010 744 753
10. W.R. ten Hove, K.S. Korkmaz, S. Op den Dries, B.J. de Rooij, B. van Hoek, and R.J. Porte Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation Liver Int 31 2011 1110 1117
11. A. Said, N. Safdar, M.R. Lucey, S.J. Knechtle, A. D'Alessandro, and A. Musat Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention Am J Transplant 4 2004 574 582 (Pubitemid 38523580)
12. A. Asensio, A. Ramos, V. Cuervas-Mons, E. Cordero, V. Sanchez-Turrion, and M. Blanes Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant Liver Transpl 14 2008 799 805 (Pubitemid 351895509)
13. A.M. de Smet, J.A. Kluytmans, B.S. Cooper, E.M. Mascini, R.F. Benus, and T.S. van der Werf Decontamination of the digestive tract and oropharynx in ICU patients N Engl J Med 360 2009 20 31
14. A.M. de Smet, J.A. Kluytmans, H.E. Blok, E.M. Mascini, R.F. Benus, and A.T. Bernards Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study Lancet Infect Dis 11 2011 372 380
15. N. Safdar, A. Said, and M.R. Lucey The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis Liver Transpl 10 2004 817 827 (Pubitemid 38979249)
16. L. Demopoulos, M. Polinsky, G. Steele, D. Mines, M. Blum, and M. Caulfield Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials Transplant Proc 40 2008 1407 1410 (Pubitemid 351853135)
17. A. Mehrabi, H. Fonouni, M. Wente, M. Sadeghi, C. Eisenbach, and J. Encke Wound complications following kidney and liver transplantation Clin Transplant 20 Suppl. 17 2006 97 110 (Pubitemid 44697907)
18. N.C. Issa, and J.A. Fishman Infectious complications of antilymphocyte therapies in solid organ transplantation Clin Infect Dis 48 2009 772 786
19. L. Llado, J. Fabregat, J. Castellote, E. Ramos, X. Xiol, and J. Torras Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study Liver Transpl 14 2008 1752 1760
20. M. Spada, W. Petz, A. Bertani, S. Riva, A. Sonzogni, and M. Giovannelli Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression Am J Transplant 6 2006 1913 1921 (Pubitemid 44024964)
21. L. Lupo, P. Panzera, F. Tandoi, G. Carbotta, G. Giannelli, and T. Santantonio Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial Transplantation 86 2008 925 931
22. P. Neuhaus, P.A. Clavien, D. Kittur, M. Salizzoni, A. Rimola, and K. Abeywickrama Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial Liver Transpl 8 2002 132 142 (Pubitemid 34202141)
23. S.J. Pelletier, K. Vanderwall, M.A. DebRoy, M.J. Englesbe, R.S. Sung, and J.C. Magee Preliminary analysis of early outcomes of a prospective, randomized trial of complete steroid avoidance in liver transplantation Transplant Proc 37 2005 1214 1216 (Pubitemid 40590840)
24. H.Y. Sun, T.V. Cacciarelli, and N. Singh Identifying a targeted population at high risk for infections after liver transplantation in the MELD era Clin Transplant 25 2011 420 425
25. C. Schramm, M. Bubenheim, R. Adam, V. Karam, J. Buckles, and J.G. O'Grady Primary liver transplantation for autoimmune hepatitis; a comparative analysis of the European Liver Transplant Registry Liver Transpl 16 2010 461 469
26. H. Nafady-Hego, H. Elgendy, W.E. Moghazy, K. Fukuda, and S. Uemoto Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: an 11-year single-center experience Liver Transpl 17 2011 976 984
27. E.E. McClelland, and J.M. Smith Gender specific differences in the immune response to infection Arch Immunol Ther Exp (Warsz) 59 2011 203 213
28. M. Takatsuki, S. Eguchi, K. Yamanouchi, M. Hidaka, A. Soyama, and K. Miyazaki The outcomes of methicillin-resistant Staphylococcus aureus infection after living donor liver transplantation in a Japanese center J Hepatobiliary Pancreat Sci 17 2010 839 843
29. N. Singh, C. Squier, C. Wannstedt, L. Keyes, M.M. Wagener, and T.V. Cacciarelli Impact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipients Infect Control Hosp Epidemiol 27 2006 122 126 (Pubitemid 43384757)
30. D. Samuel, R. Muller, G. Alexander, L. Fassati, B. Ducot, and J.P. Benhamou Liver transplantation in European patients with the hepatitis B surface antigen N Engl J Med 329 1993 1842 1847 (Pubitemid 23360483)
31. E.J. Gane, P.W. Angus, S. Strasser, D.H. Crawford, J. Ring, and G.P. Jeffrey Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation Gastroenterology 132 2007 931 937 (Pubitemid 46440868)
32. I. Campos-Varela, L. Castells, M. Buti, V. Vargas, I. Bilbao, and F. Rodriguez-Frias Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues? Ann Hepatol 10 2011 180 187
33. L.H. Katz, R. Tur-Kaspa, D.G. Guy, and M. Paul Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation Cochrane Database Syst Rev 7 2010 CD006005
34. P.W. Angus, S.J. Patterson, S.I. Strasser, G.W. McCaughan, and E. Gane A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis Hepatology 48 2008 1460 1466
35. M. Jimenez-Perez, A.B. Saez-Gomez, P.L. Mongil, J.M. Lozano-Rey, L. de lC-, and J.M. Rodrigo-Lopez Efficacy and safety of entecavir and/or tenofovir for prophylaxis and treatment of hepatitis B recurrence post-liver transplant Transplant Proc 42 2010 3167 3168
36. T. Karlas, J. Hartmann, A. Weimann, M. Maier, M. Bartels, and S. Jonas Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only Transpl Infect Dis 13 2011 299 302
37. J. Fung, C. Cheung, S.C. Chan, M.F. Yuen, K.S. Chok, and W. Sharr Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation Gastroenterology 141 2011 1212 1219
38. V. Scuderi, A. Ceriello, W. Santaniello, G. Aragiusto, M. Romano, and C. Migliaccio Hepatitis B prophylaxis in hepatitis B-negative recipients transplanted with donor grafts positive for hepatitis B core antibodies Transplant Proc 43 2011 271 273
39. M. Berenguer, J. Crippin, R. Gish, N. Bass, A. Bostrom, and G. Netto A model to predict severe HCV-related disease following liver transplantation Hepatology 38 2003 34 41 (Pubitemid 36775793)
40. R.D. Kim, S. Mizuno, J.B. Sorensen, J.J. Schwartz, and S. Fujita Impact of calcineurin inhibitors on hepatitis C recurrence after liver transplantation Dig Dis Sci 57 2012 568 572
41. M.R. Charlton, A. Thompson, B.J. Veldt, K. Watt, H. Tillmann, and J.J. Poterucha Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection Hepatology 53 2011 317 324
42. J.C. Hong, K. Kosari, E. Benjamin, J.P. Duffy, R.M. Ghobrial, and D.G. Farmer Does race influence outcomes after primary liver transplantation? A 23-year experience with 2,700 patients J Am Coll Surg 206 2008 1009 1016 (Pubitemid 351626988)
43. M. Moeller, A. Zalawadia, A. Alrayes, G. Divine, K. Brown, and D. Moonka The impact of donor race on recurrent hepatitis C after liver transplantation Transplant Proc 42 2010 4175 4177
44. L. Mensa, G. Crespo, M.J. Gastinger, J. Kabat, S. Perez-Del-Pulgar, and R. Miquel Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics Hepatology 53 2011 1436 1445
45. M. Charlton Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents - a potentially lethal cocktail Hepatology 54 2011 3 5
46. C.S. Coffin, P.G. Stock, L.M. Dove, C.L. Berg, N.N. Nissen, and M.P. Curry Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients Am J Transplant 10 2010 1268 1275
47. C. Cooper, S. Kanters, M. Klein, P. Chaudhury, P. Marotta, and P. Wong Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort AIDS 25 2011 777 786
48. D. Joshi, J. O'Grady, C. Taylor, N. Heaton, and K. Agarwal Liver transplantation in human immunodeficiency virus-positive patients Liver Transpl 17 2011 881 890
49. S.O. Lee, and R.R. Razonable Current concepts on cytomegalovirus infection after liver transplantation World J Hepatol 2 2010 325 336
50. A.J. Eid, and R.R. Razonable New developments in the management of cytomegalovirus infection after solid organ transplantation Drugs 70 2010 965 981
51. O. Shpilberg, J. Wilson, T.L. Whiteside, and R.B. Herberman Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group Leuk Lymphoma 36 1999 109 121 (Pubitemid 30011633)
52. R.R. Razonable Rare, unusual and less common virus infection after organ transplantation Curr Opin Organ Transplant 16 2011 580 587
53. R.R. Razonable, and D.M. Zerr HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients Am J Transplant 9 Suppl. 4 2009 S97 S100
54. A. Anton, C. Cervera, T. Pumarola, A. Moreno, N. Benito, and L. Linares Human herpesvirus 7 primary infection in kidney transplant recipients Transplantation 85 2008 298 302 (Pubitemid 351156862)
55. J.I. Herrero, J. Quiroga, B. Sangro, F. Pardo, F. Rotellar, and J. varez-Cienfuegos Herpes zoster after liver transplantation: incidence, risk factors, and complications Liver Transpl 10 2004 1140 1143 (Pubitemid 39248411)
56. L.M. Kucirka, A.L. Singer, and D.L. Segev High infectious risk donors: what are the risks and when are they too high? Curr Opin Organ Transplant 16 2011 256 261
57. B. Schlosser, A. Stein, R. Neuhaus, S. Pahl, B. Ramez, and D.H. Kruger Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient J Hepatol 56 2012 500 502
58. C. Franco-Paredes, J.T. Jacob, A. Hidron, A.J. Rodriguez-Morales, D. Kuhar, and A.M. Caliendo Transplantation and tropical infectious diseases Int J Infect Dis 14 2010 e189 e196
59. S.O. Lee, R.A. Brown, S.H. Kang, R.C. Abdel Massih, and R.R. Razonable Toll-like receptor 4 polymorphisms and the risk of gram-negative bacterial infections after liver transplantation Transplantation 92 2011 690 696
60. R.A. Brown, J.H. Gralewski, A.J. Eid, B.M. Knoll, R.W. Finberg, and R.R. Razonable R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins Transplantation 89 2010 811 815
61. R.A. Brown, J.H. Gralewski, and R.R. Razonable The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus Clin Infect Dis 49 2009 e96 e99
62. A.J. Eid, R.A. Brown, C.V. Paya, and R.R. Razonable Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus Transplantation 84 2007 511 516 (Pubitemid 47312163)
63. S. Kijpittayarit, A.J. Eid, R.A. Brown, C.V. Paya, and R.R. Razonable Relationship between toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation Clin Infect Dis 44 2007 1315 1320 (Pubitemid 46717293)
64. R.A. Brown, and R.R. Razonable A real-time PCR assay for the simultaneous detection of functional N284I and L412F polymorphisms in the human toll-like receptor 3 gene J Mol Diagn 12 2010 493 497
65. I.M. Bergman Toll-like receptors (TLRs) and mannan-binding lectin (MBL): on constant alert in a hostile environment Ups J Med Sci 116 2011 90 99
66. Y. Endo, M. Matsushita, and T. Fujita The role of ficolins in the lectin pathway of innate immunity Int J Biochem Cell Biol 43 2011 705 712
67. W.K. Ip, K. Takahashi, R.A. Ezekowitz, and L.M. Stuart Mannose-binding lectin and innate immunity Immunol Rev 230 2009 9 21
68. S. Thiel, T. Vorup-Jensen, C.M. Stover, W. Schwaeble, S.B. Laursen, and K. Poulsen A second serine protease associated with mannan-binding lectin that activates complement Nature 386 1997 506 510 (Pubitemid 27164078)
69. M. Matsushita, and T. Fujita Ficolins and the lectin complement pathway Immunol Rev 180 2001 78 85 (Pubitemid 32472854)
70. N.J. Lynch, S. Roscher, T. Hartung, S. Morath, M. Matsushita, and D.N. Maennel l-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement J Immunol 172 2004 1198 1202 (Pubitemid 38113782)
71. D.L. Jack, and M.W. Turner Anti-microbial activities of mannose-binding lectin Biochem Soc Trans 31 Pt 4 2003 753 757 (Pubitemid 36981119)
72. D.C. Kilpatrick Introduction to mannan-binding lectin Biochem Soc Trans 31 Pt 4 2003 745 747 (Pubitemid 36981117)
73. A.J. Nauta, G. Castellano, W. Xu, A.M. Woltman, M.C. Borrias, and M.R. Daha Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells J Immunol 173 2004 3044 3050 (Pubitemid 39142010)
74. H.O. Madsen, P. Garred, S. Thiel, J.A. Kurtzhals, L.U. Lamm, and L.P. Ryder Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein J Immunol 155 1995 3013 3020
75. F. Larsen, H.O. Madsen, R.B. Sim, C. Koch, and P. Garred Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein J Biol Chem 279 2004 21302 21311 (Pubitemid 38656537)
76. L. Munthe-Fog, T. Hummelshoj, B.E. Hansen, C. Koch, H.O. Madsen, and K. Skjodt The impact of FCN2 polymorphisms and haplotypes on the ficolin-2 serum levels Scand J Immunol 65 2007 383 392 (Pubitemid 46481107)
77. T. Hummelshoj, L. Munthe-Fog, H.O. Madsen, T. Fujita, M. Matsushita, and P. Garred Polymorphisms in the FCN2 gene determine serum variation and function of ficolin-2 Hum Mol Genet 14 2005 1651 1658 (Pubitemid 40895517)
78. J.J. Verschuren, A. Roos, A.F. Schaapherder, M.J. Mallat, M.R. Daha, and J.W. de Fijter Infectious complications after simultaneous pancreas-kidney transplantation: a role for the lectin pathway of complement activation Transplantation 85 2008 75 80
79. G. Kronborg, N. Weis, H.O. Madsen, S.S. Pedersen, C. Wejse, and H. Nielsen Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients J Infect Dis 185 2002 1517 1520 (Pubitemid 34507977)
80. M.I. Garcia-Laorden, M.J. Pena, J.A. Caminero, A. Garcia-Saavedra, M.I. Campos-Herrero, and A. Caballero Influence of mannose-binding lectin on HIV infection and tuberculosis in a Western-European population Mol Immunol 43 2006 2143 2150 (Pubitemid 43831201)
81. S.P. Berger, A. Roos, M.J. Mallat, A.F. Schaapherder, I.I. Doxiadis, and C. van Kooten Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation J Am Soc Nephrol 18 2007 2416 2422 (Pubitemid 47203858)
82. S. Thiel, R. Steffensen, I.J. Christensen, W.K. Ip, Y.L. Lau, and I.J. Reason Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms Genes Immun 8 2007 154 163 (Pubitemid 46390914)
83. K. Stengaard-Pedersen, S. Thiel, M. Gadjeva, M. Moller-Kristensen, R. Sorensen, and L.T. Jensen Inherited deficiency of mannan-binding lectin-associated serine protease 2 N Engl J Med 349 2003 554 560 (Pubitemid 36951367)
84. R. Sorensen, S. Thiel, and J.C. Jensenius Mannan-binding-lectin- associated serine proteases, characteristics and disease associations Springer Semin Immunopathol 27 2005 299 319 (Pubitemid 41639883)
85. V. Harmat, P. Gal, J. Kardos, K. Szilagyi, G. Ambrus, and B. Vegh The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions J Mol Biol 342 2004 1533 1546 (Pubitemid 39208676)
86. G. Ambrus, P. Gal, M. Kojima, K. Szilagyi, J. Balczer, and J. Antal Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments J Immunol 170 3 2003 1374 1382 (Pubitemid 36139504)
87. U. Holmskov, S. Thiel, and J.C. Jensenius Collections and ficolins: humoral lectins of the innate immune defense Annu Rev Immunol 21 2003 547 578 (Pubitemid 37174541)
88. L.H. Bouwman, A. Roos, O.T. Terpstra, P. de Knijff, B. van Hoek, and H.W. Verspaget Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation Gastroenterology 129 2005 408 414 (Pubitemid 41096628)
89. C. Cervera, D. Balderramo, B. Suarez, J. Prieto, F. Fuster, and L. Linares Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantation Liver Transpl 15 2009 1217 1224
90. D.L. Worthley, D.F. Johnson, D.P. Eisen, M.M. Dean, S.L. Heatley, and J.P. Tung Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation Clin Infect Dis 48 2009 410 417
91. R.H. Vossen, M. van Duijn, M.R. Daha, J.T. den Dunnen, and A. Roos High-throughput genotyping of mannose-binding lectin variants using high-resolution DNA-melting analysis Hum Mutat 31 2010 E1286 E1293
92. B.J. de Rooij, B. van Hoek, W.R. ten Hove, A. Roos, L.H. Bouwman, and A.F. Schaapherder Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation Hepatology 52 2010 1100 1110
93. C. Cervera, F. Lozano, N. Saval, I. Gimferrer, A. Ibanez, and B. Suarez The influence of innate immunity gene receptors polymorphisms in renal transplant infections Transplantation 83 2007 1493 1500 (Pubitemid 46934073)
94. S.P. Berger, A. Roos, M.J. Mallat, T. Fujita, J.W. de Fijter, and M.R. Daha Association between mannose-binding lectin levels and graft survival in kidney transplantation Am J Transplant 5 2005 1361 1366 (Pubitemid 40839426)
95. C. Cervera, F. Lozano, L. Linares, A. Anton, D. Balderramo, and B. Suarez Influence of mannose-binding lectin gene polymorphisms on the invasiveness of cytomegalovirus disease after solid organ transplantation Transplant Proc 41 2009 2259 2261
96. B.J. de Rooij, M.T. van der Beek, B. van Hoek, A.C. Vossen, W.R. ten Hove, and A. Roos Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation J Hepatol 55 2011 800 807
97. W.L. Chang, N. Baumgarth, D. Yu, and P.A. Barry Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality J Virol 78 2004 8720 8731 (Pubitemid 39025137)
98. M. Cederarv, C. Soderberg-Naucler, and J. Odeberg HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity Immunobiology 214 2009 331 341
99. J. Nachtwey, and J.V. Spencer HCMV IL-10 suppresses cytokine expression in monocytes through inhibition of nuclear factor-kappaB Viral Immunol 21 2008 477 482
100. O.B. Spiller, B.P. Morgan, F. Tufaro, and D.V. Devine Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells Eur J Immunol 26 1996 1532 1538 (Pubitemid 26229999)
101. G.T. Spear, N.S. Lurain, C.J. Parker, M. Ghassemi, G.H. Payne, and M. Saifuddin Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV) J Immunol 155 1995 4376 4381
102. W.K. Ip, K. Takahashi, K.J. Moore, L.M. Stuart, and R.A. Ezekowitz Mannose-binding lectin enhances toll-like receptors 2 and 6 signaling from the phagosome J Exp Med 205 2008 169 181 (Pubitemid 351185724)
103. M. Nonaka, B.Y. Ma, M. Ohtani, A. Yamamoto, M. Murata, and K. Totani Subcellular localization and physiological significance of intracellular mannan-binding protein J Biol Chem 282 2007 17908 17920 (Pubitemid 47100299)
104. N. Brouwer, F.N. Frakking, M.D. van de Wetering, M. van Houdt, M. Hart, and I.K. Budde Mannose-binding lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels J Immunol 183 2009 3496 3504
105. R.R. Razonable Innate immune genetic profile to predict infection risk and outcome after liver transplant Hepatology 52 2010 814 817
106. H. Kumar, T. Kawai, and S. Akira Pathogen recognition by the innate immune system Int Rev Immunol 30 2011 16 34